Glycopyrrolate and Formoterol and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Glycopyrrolate and Formoterol and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: formoterol / glycopyrrolate
Brand name: Bevespi Aerosphere
Synonyms: Formoterol and glycopyrrolate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycopyrrolate and Formoterol-Insulin glargine, recombinant Subcutaneous
- Glycopyrrolate and Formoterol-Insulin glulisine
- Glycopyrrolate and Formoterol-Insulin Glulisine (Cartridges and Pens)
- Glycopyrrolate and Formoterol-Insulin Glulisine (Vials)
- Glycopyrrolate and Formoterol-Insulin glulisine Subcutaneous
- Glycopyrrolate and Formoterol-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate and formoterol Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate and indacaterol inhalation
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate Capsules for Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate inhalation
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate Inhalation Solution
- Insulin glargine and lixisenatide Subcutaneous-Glycopyrrolate Injection